Event Overview

The Financial Times Global Pharma and Biotech Summit returns to London in November 2024 to explore trends and innovations in life sciences. Biopharma leaders will discuss what’s new in areas such as drug discovery, clinical trials and market access.

FT-curated content exploring important issues facing healthcare and life sciences stakeholders globally

Engage with leaders responsible for driving innovation and growth in life sciences

Discover new ideas to maximise return on investment and to manage the impact of global disruption

Understand how pharma's role in healthcare is evolving through the emergence of new technologies, partnerships and treatments

Connect with some of the biggest names in the industry, strengthen relations with clients and build new alliances

Bring your own perspective to the table by joining a flexible agenda covering a wide range of topics

“Many valuable insights and what stood out for me was the fact that FT had put together an event with so many forward-looking and important topics! Great networking facilitated by a wonderful app”

Key speakers from 2022 included:

Brent Ragans, US President, Ferring Pharmaceuticals

Maya Martinez-Davis, President, US Pharmaceuticals, GSK

Warner Biddle, Global Head of Commercial, Kite Pharma

Marion Brooks, Vice President and US Country Head, Diversity and Inclusion, Novartis

David K. Lee, CEO, Servier Pharmaceuticals

Najat Khan, Chief Data Science Officer, Janssen Research & Development, LLC

Mike Gladstone, Global President of Inflammation and Immunology, Pfizer

Belen Fraile, Global Head of Digital Medicines, Moderna

Paul Hudson, CEO, Sanofi

???,

???

???,

???

???,

???

Attendees In-Person

Speakers

Companies represented

Countries

2022 delegate

“You managed to cover all the pivotal issues facing the life science industry in one day! Amazing content and erudite speaker panels made the event a must-attend for Health industry executives.”